The latest cancer drugs news
Browsing: Cancer Drug News
Decades old mystery in leukaemia treatment solved
A research team led by the University of Kent and Goethe-University Frankfurt am Main, Germany,…
UNSW to lead new drug trial for rare blood cancer
UNSW Sydney researchers will conduct a clinical trial to establish the safety and efficacy of…
FDA grants accelerated approval to tazemetostat for follicular lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to tazemetostat, an EZH2 inhibitor, for…
FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
Cancer drug cures COVID-19 patient with acute respiratory distress
Although the spreading SARS-CoV-2 coronavirus usually causes only mild respiratory symptoms, the COVID-19 disease progresses…
AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid tumours
Treatment with the personalised cancer vaccine RO7198457 in combination with the PD-L1 inhibitor atezolizumab (Tecentriq)…
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial
A personalised cancer vaccine, used in combination with an immunotherapy drug, triggers a response from…
Cancer’s reliance on fat could be targeted with new ‘drugs and diet’ treatment
Cancers are often heavily reliant on breaking down fats for their growth and spread, and…
Breakthrough discovery to transform prostate cancer treatment
A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve…
How cancer drugs find their targets could lead to a new toolset for drug development
Researchers in Richard Young’s lab at Whitehead Institute, USA, and collaborators have discovered how certain…